M61.17 Myositis ossificans progressiva, ankle, foot and toe(s)

Name of the Condition

• Myositis Ossificans Progressiva, Ankle, Foot and Toe(s)

Summary

Myositis ossificans progressiva is a rare genetic disorder characterized by the progressive formation of heterotopic bone within muscle, tendons, and ligaments. When localized to the ankle, foot, and toe(s), this process leads to gradual replacement of soft tissue with bone, resulting in restricted movement, pain, and functional impairment over time. The condition typically begins in childhood and worsens with age, affecting the musculotendinous structures of the lower extremity.

Causes

The condition is caused by mutations in the ACVR1 gene, which disrupts normal bone and muscle development. These genetic changes disrupt signaling pathways, leading to uncontrolled bone formation in soft tissues. The disorder follows an autosomal dominant inheritance pattern, though most cases arise from new mutations.

Risk Factors

• Family history of the condition
• Presence of ACVR1 gene mutations
• Young age at onset (typically in childhood)
• Trauma or minor injury to the ankle, foot, or toe area

Symptoms

• Progressive stiffness and limited range of motion in the ankle, foot, or toes
• Pain or discomfort in affected areas
• Visible swelling or hardening of soft tissues
• Difficulty with movement or daily activities (e.g., walking, standing)
• Flare-ups triggered by minor trauma or stress to the lower extremity

Diagnosis

Diagnosis involves clinical evaluation, genetic testing for ACVR1 mutations, and imaging studies (X-rays, CT, or MRI) to detect heterotopic bone formation. Blood tests may assess inflammatory markers, and family history is reviewed to confirm the genetic basis.

Treatment Options

• Pain management with analgesics or anti-inflammatory medications
• Physical therapy to maintain mobility (avoiding aggressive manipulation)
• Surgical removal of bone formations (considered in severe cases)
• Assistive devices (e.g., braces, orthotics) to support movement

Prognosis and Follow-Up

The condition is progressive, with gradual worsening of symptoms over time. Early diagnosis and management can help preserve function, but long-term mobility limitations are common. Regular follow-up with a multidisciplinary team (orthopedics, genetics, physical therapy) is recommended to monitor progression and adjust treatment.

Complications

• Severe joint contractures or immobility
• Chronic pain
• Difficulty with weight-bearing or walking
• Increased risk of falls due to impaired mobility

Lifestyle & Prevention

• Avoid activities that may cause trauma to the lower extremity
• Use protective gear during sports or physical activities
• Maintain a healthy weight to reduce stress on joints
• Engage in gentle, low-impact exercises to preserve mobility

When to Seek Professional Help

Seek medical attention if you experience:

• Sudden worsening of pain or stiffness
• New swelling or hardening in the ankle, foot, or toes
• Difficulty bearing weight or walking
• Signs of infection (e.g., redness, warmth) in affected areas

Tips for Medical Coders

Document the specific site (ankle, foot, or toe(s)) and confirm the diagnosis of myositis ossificans progressiva. Ensure clinical notes support the genetic basis (e.g., ACVR1 mutation testing) and imaging findings consistent with heterotopic ossification. Code M61.17 is specific to the ankle, foot, and toe(s) and should not be used for other sites. Verify documentation aligns with the ICD-10-CM coding guidelines for accuracy.